Literature DB >> 15586263

[VGKC antibodies associated with limbic encephalitis].

B M Soeder1, H Urbach, C E Elger, C G Bien, S Beyenburg.   

Abstract

Since the initial description of limbic encephalitis (LE) in 1960/1968, several subforms of this clinico-neuropathological syndrome have been identified. The best known is paraneoplastic LE. However, non-paraneoplastic forms have been reported, too. Very recently, autoantibodies against voltage-gated potassium channels have been described in association with LE. The diagnostic workup of such a case and the apparently typical good response to long-term immunotherapy of this LE subform are described.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15586263     DOI: 10.1007/s00115-004-1844-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  9 in total

1.  "Limbic encephalitis" and its association with carcinoma.

Authors:  J A Corsellis; G J Goldberg; A R Norton
Journal:  Brain       Date:  1968-09       Impact factor: 13.501

2.  Potassium channel antibodies in two patients with reversible limbic encephalitis.

Authors:  C Buckley; J Oger; L Clover; E Tüzün; K Carpenter; M Jackson; A Vincent
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

3.  Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.

Authors:  S H Gultekin; M R Rosenfeld; R Voltz; J Eichen; J B Posner; J Dalmau
Journal:  Brain       Date:  2000-07       Impact factor: 13.501

4.  Human herpesvirus 6 limbic encephalitis after stem cell transplantation.

Authors:  M S Wainwright; P L Martin; R P Morse; M Lacaze; J M Provenzale; R E Coleman; M A Morgan; C Hulette; J Kurtzberg; C Bushnell; L Epstein; D V Lewis
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

5.  Hashimoto's encephalopathy: documentation of mesial temporal seizure origin by ictal EEG.

Authors:  A Arain; B Abou-Khalil; H Moses
Journal:  Seizure       Date:  2001-09       Impact factor: 3.184

6.  Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody.

Authors:  M J Thieben; V A Lennon; B F Boeve; A J Aksamit; M Keegan; S Vernino
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

7.  EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis.

Authors:  Barbara Schäuble; Pablo R Castillo; Bradley F Boeve; Barbara F Westmoreland
Journal:  Clin Neurophysiol       Date:  2003-01       Impact factor: 3.708

8.  Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.

Authors:  Angela Vincent; Camilla Buckley; Jonathan M Schott; Ian Baker; Bonnie-Kate Dewar; Niels Detert; Linda Clover; Abigail Parkinson; Christian G Bien; Salah Omer; Bethan Lang; Martin N Rossor; Jackie Palace
Journal:  Brain       Date:  2004-02-11       Impact factor: 13.501

9.  Voltage-gated potassium channel antibodies in limbic encephalitis.

Authors:  Patricia Pozo-Rosich; Linda Clover; Albert Saiz; Angela Vincent; Francesc Graus
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

  9 in total
  4 in total

1.  Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis.

Authors:  H Urbach; S Rauer; I Mader; S Paus; J Wagner; M P Malter; H Prüss; J Lewerenz; J Kassubek; H Hegen; M Auer; F Deisenhammer; F Ufer; C G Bien; A Baumgartner
Journal:  Neuroradiology       Date:  2015-08-21       Impact factor: 2.804

Review 2.  Autoimmune epilepsies.

Authors:  Christian G Bien; Jan Bauer
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

3.  Serial MRI of limbic encephalitis.

Authors:  Horst Urbach; Bettina M Soeder; Monika Jeub; Thomas Klockgether; Bernhard Meyer; Christian G Bien
Journal:  Neuroradiology       Date:  2006-04-04       Impact factor: 2.804

4.  [Pathophysiology of antibody-associated diseases of the central nervous system].

Authors:  C G Bien; J Bauer
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.